{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:34:22Z","timestamp":1790264062118,"version":"4.1.0"},"reference-count":31,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Objectives: Spondyloarthritis (SpA) is a chronic inflammatory arthritis that mainly affects the sacroiliac joints and spine. Despite effective biological treatments, persistent pain is common in SpA patients, potentially due to central sensitization (CS), a condition of heightened central nervous system responsiveness. The purpose of this study was to investigate the link between disease activity and CS in SpA patients on biological therapy. Patients and Methods: One hundred and twenty SpA patients with at least six months of treatment with biological agents were included in this cross-sectional study. Patients\u2019 demographic, clinical, and functional information were collected. The assessment of CS was conducted using the Central Sensitization Inventory (CSI), whereas disease activity and quality of life were evaluated using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Ankylosing Spondylitis Disease Activity Score (ASDAS)-C-reactive protein (CRP), and Ankylosing Spondylitis Quality of Life (ASQoL). Statistical analyses included correlation assessments and logistic regression to identify predictors of CS. Results: CS (CSI \u2265 40) was present in 40.8% of patients. Disease activity was significantly higher and quality of life was lower in patients with CS. BASDAI and ASQoL scores were strongly correlated with CS (r = 0.774 and r = 0.839, respectively). Logistic regression identified ASQoL and BASDAI scores as independent predictors of CS. ROC curve analysis demonstrated that ASQoL had the highest discriminative ability for predicting CS (AUC = 0.97). Conclusions: CS is significantly associated with higher disease activity and poorer quality of life in SpA patients receiving biological therapy. Incorporating CS assessment into routine clinical practice may enhance our understanding and management of persistent symptoms in SpA, improving patient outcomes.<\/jats:p>","DOI":"10.3390\/medicina61020319","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T03:41:57Z","timestamp":1739331717000},"page":"319","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Central Sensitization and Its Role in Persistent Pain Among Spondyloarthritis Patients on Biological Treatments"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1002-962X","authenticated-orcid":false,"given":"Nuran","family":"\u00d6z","sequence":"first","affiliation":[{"name":"Physical Medicine and Rehabilitation Department, Rheumatology Division, Marmara University School of Medicine, 34899 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayg\u00fcn","family":"\u00d6zer","sequence":"additional","affiliation":[{"name":"Physical Medicine and Rehabilitation Department, Rheumatology Division, Abant Izzet Baysal Training and Research Hospital, 14280 Bolu, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Tuncay","family":"Duru\u00f6z","sequence":"additional","affiliation":[{"name":"Physical Medicine and Rehabilitation Department, Rheumatology Division, Marmara University School of Medicine, 34899 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"ref_1","first-page":"361.e8","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"Valkenburg","year":"1984","journal-title":"Arthritis Rheum."},{"key":"ref_2","first-page":"293","article-title":"Evaluation of the Amor and ESSG classification criteria for spondylarthropathies in a Turkish population","volume":"64","author":"Erturk","year":"1997","journal-title":"Rev. Rhum. Engl. Ed."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the manage- ment of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5114\/reum\/185429","article-title":"Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity","volume":"62","author":"Wielosz","year":"2024","journal-title":"Reumatologia"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Liu, D., Xie, Y., Tu, L., Wen, X., Lv, Q., Liu, B., Yang, M., Wu, X., Zheng, X., and Luo, X. (2024). A guideline on biomarkers in the diagnosis and evaluation in axial spondyloarthritis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1394148"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"151933","DOI":"10.1016\/j.semarthrit.2021.11.006","article-title":"Central sensitization has major impact on quality of life in patients with axial spondyloarthritis","volume":"52","author":"Kieskamp","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/mr\/roab110","article-title":"Central sensitization in axial spondyloarthritis: An explorative study with quantitative sensory testing and clinical scales","volume":"32","year":"2022","journal-title":"Mod. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1093\/rheumatology\/keab019","article-title":"Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis","volume":"60","author":"Kieskamp","year":"2021","journal-title":"Rheumatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101970","DOI":"10.1016\/j.berh.2024.101970","article-title":"Inflammatory or non-inflammatory pain in inflammatory arthritis-How to differentiate it?","volume":"38","author":"Pellegrino","year":"2024","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3899\/jrheum.210137","article-title":"Pain in axial spondyloarthritis: More to it than just inflammation","volume":"48","author":"Magrey","year":"2021","journal-title":"J. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/bs.irn.2024.10.009","article-title":"Exploring neuroinflammation: A key driver in neuropathic pain disorders","volume":"179","author":"Scheuren","year":"2024","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.62347\/YXRQ5742","article-title":"Ligustrazine alleviates spinal cord injury-induced neuropathic pain by inhibiting the TLR4\/NF-\u03baB signaling pathway","volume":"16","author":"Jin","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3949\/ccjm.90a.22019","article-title":"Central sensitization, chronic pain, and other symptoms: Better understanding, better management","volume":"90","author":"Volcheck","year":"2023","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/ard.2008.101501","article-title":"New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1533-2500.2011.00493.x","article-title":"The development and psychometric validation of the central sensitization inventory","volume":"12","author":"Mayer","year":"2012","journal-title":"Pain Pract."},{"key":"ref_16","first-page":"518","article-title":"Validity and reliability of the Turkish version of the central sensitization inventory","volume":"36","author":"Birtane","year":"2021","journal-title":"Arch. Rheumatol."},{"key":"ref_17","first-page":"2286","article-title":"A new approach to defining disease status in anky- losing spondylitis: The bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_19","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: The development of the bath ankylosing spondylitis functional index","volume":"21","author":"Calin","year":"1994","journal-title":"J. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/ard.2007.074724","article-title":"Proposal of a linear definition of the bath ankylosing spondylitis metrology index (BASMI) and comparison with the 2-step and 10-step definitions","volume":"67","author":"Feldtkeller","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.62.2.127","article-title":"Assessment of enthesitis in ankylosing spondylitis","volume":"62","author":"Spoorenberg","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.62.1.20","article-title":"Devel- opment of the ASQoL: A quality of life instrument specific to ankylosing spondylitis","volume":"62","author":"Doward","year":"2003","journal-title":"Ann. Rheum. Dis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"101439","DOI":"10.1016\/j.berh.2019.101439","article-title":"Pain without inflammation in rheumatic diseases","volume":"33","author":"Lampa","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.berh.2018.07.003","article-title":"Pain in spondyloarthritis: A neuro-immune interaction","volume":"31","author":"Pathan","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4078\/jrd.2023.0009","article-title":"The effect of central sensitization on disease activity measures, quality of life and clinical parameters in axial spondyloarthritis: A cross-sectional study","volume":"30","author":"Cengiz","year":"2023","journal-title":"J. Rheum. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3899\/jrheum.150463","article-title":"Fatigue in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Analysis from a Longitudinal Observation Cohort","volume":"42","author":"Bedaiwi","year":"2015","journal-title":"J. Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/rheumatology\/kez028","article-title":"Central sensitization predicts greater fatigue independently of musculoskeletal pain","volume":"58","author":"Druce","year":"2019","journal-title":"Rheumatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4203.e19","DOI":"10.1007\/s00429-015-1161-1","article-title":"Abnormal inter-network functional connectivity in chronic pain and its relationship to clinical symptoms","volume":"221","author":"Hemington","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","article-title":"Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation","volume":"38","author":"Verri","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00296-023-05317-2","article-title":"Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis","volume":"43","author":"Sariyildiz","year":"2023","journal-title":"Rheumatol. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/14656566.2019.1647166","article-title":"Treatment of central sensitization in patients with chronic pain: Time for change?","volume":"20","author":"Nijs","year":"2019","journal-title":"Expert Opin. Pharmacother."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/319\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:31:51Z","timestamp":1760027511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["medicina61020319"],"URL":"https:\/\/doi.org\/10.3390\/medicina61020319","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]}}}